NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices | MicrobiomeTrials← Back to trialsNCT07806149
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2029-03-01
Enrollment target: 200 participants Locations- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Emory University Hospital, Atlanta, Georgia, United States
- National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- St. Francis Hospital & Heart Center, Roslyn, New York, United States
- Montefiore Medical Center: Einstein Campus, The Bronx, New York, United States
- WellSpan York Hospital, York, Pennsylvania, United States
- Univ. of Virginia, Charlottesville, Virginia, United States
- Carilion Roanoke Memorial Hospital, Roanoke, Virginia, United States
Other microbiome trials you might be interested in
Acute Pain
This pilot study will test an innovative way to establish how pain medicines provide analgesia in healthy adults. The st…
Bethesda, United StatesEst. completion Dec 31, 2029
Cardiomyopathy, Hypertrophic Obstructive
The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of o…
Multiple LocationsEst. completion Oct 2028